Mega Lifesciences PCL
Thai stocks · SET · Healthcare · Pharmaceuticals and supplements
Makes its own brands of vitamins, supplements and medicines, sold through agents in Southeast Asia and Africa, and distributes products for other companies, so profit depends on overseas sales and those countries' currencies
For every 100 baht of sales: cost of sales 48 · operating expenses 31 · other items 3 · tax and other items 4 · leaving 14 as net profit
Investors in Thailand can buy MEGA through 9 mutual funds open to retail investors. Every one of them buys the stock directly.
| Fund | MEGA weight | How it invests | 1-year return |
|---|---|---|---|
 ABTEDabrdn Thai Equity Dividend Fund | 6.06% | Buys the stock directly | +19.08% |
| ABMIX70Aberdeen Mixed 70 Opportunities Fund | 5.74% | Buys the stock directly | +13.32% |
 PMIXPhillip Mixed Fund | 4.88% | Buys the stock directly | +15.82% |
 TISCOMS-ATISCO Mid/Small Cap Equity Fund | 4.85% | Buys the stock directly | +26.88% |
| TMSFOCUS-ATISCO Thai Mid/Small Equity Focus Fund | 4.83% | Buys the stock directly | +26.83% |
| TMSRMF-ATISCO Mid/Small Cap Equity RMF | 4.81% | Buys the stock directly | +26.44% |
| PMIXRMFPHILLIP MIXED RETIREMENT MUTUAL FUND | 3.96% | Buys the stock directly | +12.99% |
 KFTHAISMKrungsri Thai Small-Mid Cap Equity Fund | 3.78% | Buys the stock directly | +23.10% |
| KFTHAISM2-DKrungsri Thai Small-Mid Cap Equity Fund 2 | 3.76% | Buys the stock directly | +2.43% |
Yearly average over the last 3 years · Latest annual sales 14.1B THB
For every 100 baht of sales, about 14 baht is left as net profit
Per year, relative to the share price · Tech stocks tend to pay little because they reinvest their profits
Now 10.7% below its 1-year high
| Item (THB) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total revenue | 15.7B THB | 15.7B THB | 15.3B THB | 14.1B THB |
| Gross profit | 7.0B THB | 7.1B THB | 7.8B THB | 7.4B THB |
| Operating profit | 2.6B THB | 2.3B THB | 2.4B THB | 2.5B THB |
| Net profit | 2.2B THB | 2.0B THB | 2.0B THB | 1.9B THB |
| EPS (diluted) | 2.57 | 2.29 | 2.31 | 2.19 |
| Gross margin | 44.9% | 45.2% | 50.5% | 52.2% |
| Operating margin | 16.7% | 14.6% | 15.6% | 17.4% |
| Net margin | 14.3% | 12.7% | 13.1% | 13.5% |
| Operating cash flow | 2.0B THB | 1.9B THB | 2.4B THB | 2.8B THB |
| Free cash flow | 1.7B THB | 1.7B THB | 2.2B THB | 2.1B THB |
| Total assets | 14.6B THB | 14.1B THB | 14.2B THB | 15.8B THB |
| Total liabilities | 5.9B THB | 4.8B THB | 4.3B THB | 5.5B THB |
| Shareholders' equity | 8.8B THB | 9.3B THB | 9.9B THB | 10.2B THB |
| Period | SMA | EMA | Price vs line |
|---|---|---|---|
| 10 days | 33.90 | 34.03 | Above |
| 20 days | 33.59 | 33.99 | Above |
| 50 days | 34.81 | 34.69 | Above |
| 100 days | 35.88 | 35.19 | Below |
| 200 days | 35.69 | 34.93 | Below |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 60.34 | Up |
| MACD(12,26) | −0.14 | Down |
| ADX(14) | 28.26 | Neutral |
| ATR(14) % of price | 1.43 | Neutral |
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
TISCOASSET3ABERDEEN2PAMC2KSAM2| Fund | MEGA weight | Master fund | 1-year return | TER |
|---|---|---|---|---|
| ABTED | 6.06% | Buys the stock directly | +19.08% | 2.18% |
| ABMIX70 | 5.74% | Buys the stock directly | +13.32% | 1.98% |
| PMIX | 4.88% | Buys the stock directly | +15.82% | 1.77% |
| TISCOMS-A | 4.85% | Buys the stock directly | +26.88% | 2.09% |
| TMSFOCUS-A | 4.83% | Buys the stock directly | +26.83% | 2.03% |
| TMSRMF-A | 4.81% | Buys the stock directly | +26.44% | 2.39% |
| PMIXRMF | 3.96% | Buys the stock directly | +12.99% | 1.83% |
| KFTHAISM | 3.78% | Buys the stock directly | +23.10% | 1.84% |
| KFTHAISM2-D | 3.76% | Buys the stock directly | +2.43% | 1.81% |
